116 related articles for article (PubMed ID: 16509595)
1. A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma.
Ingrassia L; Nshimyumukiza P; Dewelle J; Lefranc F; Wlodarczak L; Thomas S; Dielie G; Chiron C; Zedde C; Tisnès P; van Soest R; Braekman JC; Darro F; Kiss R
J Med Chem; 2006 Mar; 49(5):1800-7. PubMed ID: 16509595
[TBL] [Abstract][Full Text] [Related]
2. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
Narla RK; Liu XP; Myers DE; Uckun FM
Clin Cancer Res; 1998 Jun; 4(6):1405-14. PubMed ID: 9626456
[TBL] [Abstract][Full Text] [Related]
3. Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines.
Mégalizzi V; Decaestecker C; Debeir O; Spiegl-Kreinecker S; Berger W; Lefranc F; Kast RE; Kiss R
Eur J Cancer; 2009 Nov; 45(16):2893-905. PubMed ID: 19679463
[TBL] [Abstract][Full Text] [Related]
4. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
5. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
6. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.
Mégalizzi V; Mathieu V; Mijatovic T; Gailly P; Debeir O; De Neve N; Van Damme M; Bontempi G; Haibe-Kains B; Decaestecker C; Kondo Y; Kiss R; Lefranc F
Neoplasia; 2007 May; 9(5):358-69. PubMed ID: 17534441
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo.
Wendt MD; Shen W; Kunzer A; McClellan WJ; Bruncko M; Oost TK; Ding H; Joseph MK; Zhang H; Nimmer PM; Ng SC; Shoemaker AR; Petros AM; Oleksijew A; Marsh K; Bauch J; Oltersdorf T; Belli BA; Martineau D; Fesik SW; Rosenberg SH; Elmore SW
J Med Chem; 2006 Feb; 49(3):1165-81. PubMed ID: 16451081
[TBL] [Abstract][Full Text] [Related]
8. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
10. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
11. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
12. Tumor specific cytotoxicity of beta-glucosylceramide: structure-cytotoxicity relationship and anti-tumor activity in vivo.
Oku H; Li C; Shimatani M; Iwasaki H; Toda T; Okabe T; Watanabe H
Cancer Chemother Pharmacol; 2009 Aug; 64(3):485-96. PubMed ID: 19104811
[TBL] [Abstract][Full Text] [Related]
13. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4).
Raffaghello L; Zuccari G; Carosio R; Orienti I; Montaldo PG
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3485-93. PubMed ID: 16740774
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C
J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy resistance of glioblastoma stem cells.
Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
[No Abstract] [Full Text] [Related]
17. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
18. Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines.
Li B; Lyle MP; Chen G; Li J; Hu K; Tang L; Alaoui-Jamali MA; Webster J
Bioorg Med Chem; 2007 Jul; 15(13):4601-8. PubMed ID: 17467996
[TBL] [Abstract][Full Text] [Related]
19. A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo.
Shoemaker AR; Oleksijew A; Bauch J; Belli BA; Borre T; Bruncko M; Deckwirth T; Frost DJ; Jarvis K; Joseph MK; Marsh K; McClellan W; Nellans H; Ng S; Nimmer P; O'Connor JM; Oltersdorf T; Qing W; Shen W; Stavropoulos J; Tahir SK; Wang B; Warner R; Zhang H; Fesik SW; Rosenberg SH; Elmore SW
Cancer Res; 2006 Sep; 66(17):8731-9. PubMed ID: 16951189
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
Gourdeau H; McAlpine JB; Ranger M; Simard B; Berger F; Beaudry F; Farnet CM; Falardeau P
Cancer Chemother Pharmacol; 2008 May; 61(6):911-21. PubMed ID: 17622531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
